These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1738200)

  • 1. Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression.
    Dropulić B; Lin NH; Martin MA; Jeang KT
    J Virol; 1992 Mar; 66(3):1432-41. PubMed ID: 1738200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
    Yamada O; Kraus G; Luznik L; Yu M; Wong-Staal F
    J Virol; 1996 Mar; 70(3):1596-601. PubMed ID: 8627679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes.
    Leavitt MC; Yu M; Yamada O; Kraus G; Looney D; Poeschla E; Wong-Staal F
    Hum Gene Ther; 1994 Sep; 5(9):1115-20. PubMed ID: 7833371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of a hairpin ribozyme sequence in HIV-1 is required for efficient viral replication.
    Yamada O; Kraus G; Sargueil B; Yu Q; Burke JM; Wong-Staal F
    Virology; 1996 Jun; 220(2):361-6. PubMed ID: 8661387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme.
    Ojwang JO; Hampel A; Looney DJ; Wong-Staal F; Rappaport J
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10802-6. PubMed ID: 1438280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.
    Lo KM; Biasolo MA; Dehni G; Palú G; Haseltine WA
    Virology; 1992 Sep; 190(1):176-83. PubMed ID: 1529527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular susceptibility to ribozymes in a tethered substrate-ribozyme provirus model is not predicted by secondary structures of human immunodeficiency virus type 1 RNAs in vitro.
    Dropulić B; Jeang KT
    Antisense Res Dev; 1994; 4(3):217-21. PubMed ID: 7849493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
    Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme.
    Weerasinghe M; Liem SE; Asad S; Read SE; Joshi S
    J Virol; 1991 Oct; 65(10):5531-4. PubMed ID: 1895402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 replication by an HIV-1 dependent ribozyme expression vector with the Cre/loxP (ON/OFF) system.
    Habu Y; Miyano-Kurosaki N; Nagawa T; Matsumoto N; Takeuchi H; Takaku H
    Antivir Chem Chemother; 2002 Sep; 13(5):273-81. PubMed ID: 12630675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.
    Vicenzi E; Dimitrov DS; Engelman A; Migone TS; Purcell DF; Leonard J; Englund G; Martin MA
    J Virol; 1994 Dec; 68(12):7879-90. PubMed ID: 7966578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.
    Beerens N; Groot F; Berkhout B
    Nucleic Acids Res; 2000 Nov; 28(21):4130-7. PubMed ID: 11058109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of human immunodeficiency virus type 1 (HIV-1) replication by an HIV-1-dependent double locked vector with the Cre/loxP system.
    Habu Y; Nagawa T; Matsumoto N; Takeuchi H; Miyano-Kurosaki N; Takaku H
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1907-17. PubMed ID: 16438057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the human immunodeficiency virus type 1 primer binding sequence inhibits HIV-1 replication.
    Kechli AM; Freiden PJ; Rossi JJ; Brenner MK; Choueiry MA; Garcia JV; Slobod KS
    Hum Gene Ther; 1998 Mar; 9(4):587-90. PubMed ID: 9525319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome.
    Beerens N; Klaver B; Berkhout B
    J Virol; 2000 Mar; 74(5):2227-38. PubMed ID: 10666253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.